Worldwide Clinical Experience With the First Marketed Leukotriene Receptor Antagonist

This publication has 11 references indexed in Scilit:

• Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma
  Thorax, 1997
• Concentrations of chemical mediators in nasal secretions after nasal allergen challenges in atopic patients
  European Archives of Oto-Rhino-Laryngology, 1995
• Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.
  American Journal of Respiratory and Critical Care Medicine, 1994
• Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078.
  American Journal of Respiratory and Critical Care Medicine, 1994
• The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects
  Journal of Allergy and Clinical Immunology, 1993
• Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma
  Respiratory Medicine, 1993
• The Role of Leukotrienes in Allergic Rhinitis: A Review
  American Review of Respiratory Disease, 1991
• A Specific LTD₄/LTE₄receptor Antagonist Improves Pulmonary Function in Patients with Mild, Chronic Asthma
  American Review of Respiratory Disease, 1989
• Release of Leukotrienes, Prostaglandins, and Histamine into Nasal Secretions of Aspirin-sensitive Asthmatics during Reaction to Aspirin
  American Review of Respiratory Disease, 1988
• Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to Ragweed
  New England Journal of Medicine, 1984